Following the release of the latest accountable care organization (ACO) participation numbers from the CMS, the National Association of ACOs (NAACOS) authored its own take on the latest data around the Medicare Shared Savings Program, Medicare’s largest and most prominent value-based payment program serving 11 million patients.
Following the release of the latest accountable care organization (ACO) participation numbers from the CMS, the National Association of ACOs (NAACOS) authored its own take on the latest data around the Medicare Shared Savings Program, Medicare’s largest and most prominent value-based payment program serving 11 million patients. That take was published today in the Health Affairs Blog.
CMS, last year, enacted several changes to the ACO program, emphasizing the need to take on financial risk for assigned patients. When those changes took effect on July 1, participation in Medicare’s preeminent ACO program fell from 561 to 518. While not yet a reason to sound an alarm, the dip in participation in 2019 will be problematic for Medicare if it continues, and policy makers should pay close attention as we move forward. ACOs are the dominant alternative payment model that exists today, and if participation drops following CMS’s changes last year, it threatens years of work to transform our delivery and payment system to better reward value and quality. This year could be an anomaly given the midyear application cycle and ACOs waiting to see how last year’s regulatory changes unfold.
Evidence continues to build that ACOs are helping Medicare lower the rate of spending. More “counterfactual” data, which compares Medicare spending to what spending would be like in the absence of ACOs, are available and all show ACOs are lowering Medicare spending by 1% to 2%, which translates into tens of billions of dollars of reduced Medicare spending when compounded annually. Researchers at Harvard University, the Medicare Payment Advisory Commission, and NAACOS have all done such work.
Medicare ACOs in 2017 showed a continuing trend of ACOs saving money compared to the CMS-set benchmarks. CMS acknowledged “spillover” savings in last August’s proposed Pathways rule, pointing out that ACOs lowered Medicare spending outside the ACO program by $1.8—$4.2 billion in 2016 alone in such ways as lower Medicare Advantage payments.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen